Siemens offers $1.86bn to acquire DPC (Diagnostic Products Corporation) to "bridge in vivo and in vitro diagnostics gap"
This article was originally published in Clinica
Executive Summary
Siemens Medical Solutions, one of the leading medical imaging and healthcare IT players, is to enter the in vitro diagnostics market with the acquisition of Diagnostic Products Corporation (DPC) for $1.86bn.
You may also be interested in...
Quotable: Words Of Wisdom From Our Recent APAC Coverage
Scrip's APAC team selects notable quotes from recent interviews, conferences and other coverage to highlight the views of senior executives and officials on the major topics facing the biopharma sector in the region.
Generic Or Innovator? Sandoz Sues CMS Over Potential Change In Rebate Classification
Sandoz argued against paying higher rebates for two of its drugs via the Centers for Medicare and Medicaid Services’ Medicaid drug rebate program in a US court six years after the suggestion was first made.
Ultrahuman Expands Wearable Medtech Production Into US After $35M Funding Round
Firm operating in London, India and United Arab Emirates says its “Ultra Factory” will open in Indiana within the next six months with end-to-end production based on its operational facility in India.